Most times in our life we use products with little understanding of how and why the packaging was selected. We usually don’t think about the …
This article, by Luke Beedle, Sales Support Manager at Sharp Clinical Services, provides an overview of why de-blistering is required, what issues this creates, and …
On 9 February 2016, the European Parliament and Council published the amended version of the Falsified Medicines Directive (FMD), detailing the characteristics of the security …
Pharmaceutical manufacturers are facing a new challenge. The recent patent cliff and the exponential growth in the development of high-value pharmaceutical products, biologically developed therapies …
Over the past several years, there has been a steady rise in new biologic drugs coming onto the market for the treatment of chronic conditions …
Industry 4.0 will be a game changer in how the patient will interact with all the partners who are involved in all aspects of the …
The intentions of the current study are to expedite the compliance requirements to support the regulatory approval for selected pharmaceuticals in the United States, the …
New technologies allow for direct patient care and necessitate an overhaul in the focus of healthcare industry business models. It is becoming clear that in …
The life sciences industry has always been incredibly innovative in its R&D and bringing new life-saving and -changing medicines, devices, diagnostic tools and products to …
R&D generates a wealth of vital data, which is pivotal to everything else a life sciences organisation does. Yet there is often great diversity in …
IPI was established by professionals with over 30 years of experience in the Pharmaceutical and Life sciences publishing sectors. Peer-Reviewed, Contemporary, Authoritative
